Skip to content

Clinical trials

Completed Candidiasis, Vulvovaginal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Vulvovaginal Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20043
20071
20082
20104
20112
20121
20136
20144
20154
20166
20173
20183
20197
20204
20212
20225
20236
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Scynexis, Inc.8
Bayer3
Gedea Biotech AB3
Mycovia Pharmaceuticals Inc.3
Peking University Shenzhen Hospital3
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
National Institute of Allergy and Infectious Diseases (NIAID)2
Padagis LLC2
Viamet2
Agency for Healthcare Research and Quality (AHRQ)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Vulvovaginal70
Vaginosis, Bacterial17
Candidiasis10
Vaginitis10
Trichomonas Vaginitis7
Mycoses5
Trichomonas Infections3
Vaginal Diseases3
Vulvovaginitis3
Genital Diseases, Female2

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.